This one-hour course equips healthcare professionals with practical strategies to navigate the complex challenges of buprenorphine prescribing for opioid use disorder (OUD) in both hospital and clinic settings.

This one-hour, on-demand, journal article-based activity presents original research on the prescribing of medications for alcohol use disorder (MAUD) among birthing people with an alcohol-related diagnosis. Although safety and effectiveness of medications for alcohol use disorder (MAUD) are generally well established for adults, the literature on its use in pregnancy is limited. To better understand the benefit and risks of medications for AUD in pregnancy, this study offers an analysis of insurance claim data to estimate the prevalence of birthing people currently receiving prescriptions for medications for alcohol use disorder.

This four-episode podcast series focused on improving hospital and clinic-based buprenorphine treatment for OUD provides experts insights, practical strategies, and real-world approaches to overcoming common challenges.

This 8-hour, online course provides the education that is essential for providers to identify, assess, diagnose, and manage pregnant and postpartum patients with opioid use disorder (OUD).

This one-hour, on-demand, journal article-based activity presents original research concerning the integration of a community Opioid Treatment Program (OTP) into a Federally Qualified Health Center (FQHC), an approach to expand access to methadone treatment and to promote retention in treatment among patients with opioid use disorder. This study validates this model as a way to increase access to both treatment for OUD and primary care for urban, underserved patient populations.

This 2-hour, on-demand session from the 2024 ASAM State of the Art Course focuses on the prevention and treatment of stimulant use disorders and will discuss topics such as new clinical practice guidelines, novel pharmacotherapies, methamphetamine-induced psychotic disorders, and more.

This 1-hour, on-demand session from the 2024 ASAM State of the Art Course covers most recent updates on emerging issues and advances in addiction medicine from the perspective of three major federal agencies: NIAAA, SAMHSA, and NIDA.

This 1-hour, on-demand session from the 2024 ASAM State of the Art Course outlines recent interesting findings and topics that have emerged, from differences in formulations and routes of administration to ways research may impact the future of policy.

This 1-hour and 45-minute, on-demand session from the 2024 ASAM State of the Art Course discusses tobacco use in different populations, GLP-1 use for smoking cessation, comparative effectiveness of treatment models, and more, to provide a comprehensive overview of the state of the art of treatment for nicotine use disorder.

This 2-hour, on-demand session from the 2024 ASAM State of the Art Course examines new research on AUD treatment, including spironolactone, psychedelics, GLP-1, and technology-assisted approaches.